Dr. Julie Schatteman Nucleaire Geneeskunde SRL
Dr. Julie Schatteman Nucleaire Geneeskunde reported total assets of 385,349 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jun 2026).
By total assets for 2025, Dr. Julie Schatteman Nucleaire Geneeskunde ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. Julie Schatteman Nucleaire Geneeskunde shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +181 % Total assets +139 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Julie Schatteman Nucleaire Geneeskunde's annual accounts
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Net result | 150,964 € | |||
| Equity | 379,327 € | |||
| Cash | 118,021 € | |||
| EBITDA | 194,927 € | |||
| Total assets | 385,349 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jun 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 24 Jul 2023
Dr. Julie Schatteman Nucleaire Geneeskunde's financial analysis
- Solvency98.4%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Julie Schatteman Nucleaire Geneeskunde
1 active director(s) in the register.
Dr. Julie Schatteman Nucleaire Geneeskunde's shareholders and holdings →Dr. Julie Schatteman Nucleaire Geneeskunde's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0777.847.156
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 30 Nov 2021
- Registered office
- 9160 Lokeren
- Latest accounts
- 2025 · filed on 16 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Julie Schatteman Nucleaire Geneeskunde (SRL) has been based in Lokeren since 2021, active in: medical specialists activities. For 2025, it reports a net profit of 150,964 € and equity of 379,327 €; its revenue is not published. Its solvency stands at 98.4%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Julie Schatteman Nucleaire Geneeskunde
Companies in the same business, of comparable size and area, outside its group.
- Appache Ottignies-Louvain-la-Neuve · balance sheet 385,085 €
- Brouwerij van Eecke Manufacture of beer Ypres · balance sheet 385,668 €
- DR Zahraoui Laïla, Gynecologie - Verloskunde Publishing of books Dilbeek · balance sheet 385,698 €
- D & L Immo Liège · balance sheet 385,408 €
- Soins Infirmiers Dehant-Loze Couvin · balance sheet 385,176 €
- C.P.L.L. Immo Bernissart · balance sheet 385,150 €
- Cabinet Médical du Docteur Bernard Brickmanne Charleroi · balance sheet 385,550 €
- Acute Medical Management Dour · balance sheet 385,062 €
Frequently asked questions about Dr. Julie Schatteman Nucleaire Geneeskunde
What is the revenue of Dr. Julie Schatteman Nucleaire Geneeskunde?
Dr. Julie Schatteman Nucleaire Geneeskunde files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Julie Schatteman Nucleaire Geneeskunde?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dr. Julie Schatteman Nucleaire Geneeskunde. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0777847156. Its company number (CBE) is 0777.847.156.
Where is the registered office of Dr. Julie Schatteman Nucleaire Geneeskunde?
According to the CBE register, the registered office of Dr. Julie Schatteman Nucleaire Geneeskunde is in 9160 Lokeren.
What is the equity of Dr. Julie Schatteman Nucleaire Geneeskunde?
At the close of the 2025 financial year, the equity of Dr. Julie Schatteman Nucleaire Geneeskunde amounts to 379,327 €, a solvency of 98.4% of total assets.
Who manages Dr. Julie Schatteman Nucleaire Geneeskunde?
The register lists 1 active mandates at Dr. Julie Schatteman Nucleaire Geneeskunde. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. Julie Schatteman Nucleaire Geneeskunde within its sector?
By total assets for 2025, Dr. Julie Schatteman Nucleaire Geneeskunde ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Dr. Julie Schatteman Nucleaire Geneeskunde
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →